GPX4 and lung carcinoma: As an important rate‐limiting enzyme in fatty acid oxidation, CPT1A was reported to stabilize c‐Myc and activate the NRF2/GPX4 system to suppress ferroptosis and improve the efficacy of immunotherapy in lung cancer cells [24].